Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms
- PMID: 16681034
- DOI: 10.1007/BF02968573
Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms
Abstract
The fruits of Evodia rutaecarpa Benth (Rutaceae) has long been used for inflammatory disorders and some anti-inflammatory actions of its constituents such as dehydroevodiamine, evodiamine and rutaecarpine were previously reported. Since the pharmacological data is not sufficient to clearly establish the scientific rationale of anti-inflammatory medicinal use of this plant material and the search for its active principles is limited so far, three major constituents (evodiamine, rutaecarpine, goshuyuamide II) were evaluated for their anti-inflammatory cellular action mechanisms in the present study. From the results, evodiamine and rutaecarpine were found to strongly inhibit prostaglandin E2 synthesis from lipopolysaccharide-treated RAW 264.7 cells at 1-10 microM. Evodiamine inhibited cyclooxygenase-2 induction and NF-kappaB activation, while rutaecarpine did not. On the other hand, goshuyuamide II inhibited 5-lipoxygenase from RBL-1 cells (IC50 = 6.6 microM), resulting in the reduced synthesis of leukotrienes. However, these three compounds were not inhibitory against inducible nitric oxide synthase-mediated nitric oxide production from RAW cells up to 50 micorM. These pharmacological properties may provide the additional scientific rationale for anti-inflammatory use of the fruits of E. rutaecarpa.
Similar articles
-
Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases.Biomed Pharmacother. 2023 Nov;167:115495. doi: 10.1016/j.biopha.2023.115495. Epub 2023 Sep 21. Biomed Pharmacother. 2023. PMID: 37741256 Review.
-
Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu).Pharmacol Res. 2019 Mar;141:541-550. doi: 10.1016/j.phrs.2018.12.019. Epub 2019 Jan 4. Pharmacol Res. 2019. PMID: 30616017 Review.
-
In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents.Biol Pharm Bull. 2007 Jan;30(1):197-9. doi: 10.1248/bpb.30.197. Biol Pharm Bull. 2007. PMID: 17202687
-
Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells.Eur J Pharmacol. 2007 Jan 26;555(2-3):211-7. doi: 10.1016/j.ejphar.2006.10.002. Epub 2006 Oct 17. Eur J Pharmacol. 2007. PMID: 17109845
-
The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors.Planta Med. 2001 Apr;67(3):244-8. doi: 10.1055/s-2001-12008. Planta Med. 2001. PMID: 11345696
Cited by
-
Evodiamine Alleviates 2,4-Dinitro-1-Chloro-Benzene-Induced Atopic Dermatitis-like Symptoms in BALB/c Mice.Life (Basel). 2024 Apr 11;14(4):494. doi: 10.3390/life14040494. Life (Basel). 2024. PMID: 38672764 Free PMC article.
-
Persulfate-Promoted Carbamoylation/Cyclization of Alkenes: Synthesis of Amide-Containing Quinazolinones.Molecules. 2024 Feb 25;29(5):997. doi: 10.3390/molecules29050997. Molecules. 2024. PMID: 38474508 Free PMC article.
-
Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions.Front Nutr. 2023 Jul 5;10:1190912. doi: 10.3389/fnut.2023.1190912. eCollection 2023. Front Nutr. 2023. PMID: 37476406 Free PMC article. Review.
-
Differences in tissue distribution ability of evodiamine and dehydroevodiamine are due to the dihedral angle of the molecule stereo-structure.Front Pharmacol. 2023 Apr 6;14:1109279. doi: 10.3389/fphar.2023.1109279. eCollection 2023. Front Pharmacol. 2023. PMID: 37089948 Free PMC article.
-
The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: A review.Front Pharmacol. 2022 Nov 18;13:1040154. doi: 10.3389/fphar.2022.1040154. eCollection 2022. Front Pharmacol. 2022. PMID: 36467053 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials